Espoo, 02 December 2021 – Nordic BioTech Group Ltd, marketed as NordShield® ("NordShield®") is proud to announce its acceptance as Technology Brand Member in the Scandinavian Outdoor Group ("SOG")
The Scandinavian Outdoor Group has approx. 70 member companies representing premium outdoor brands from Nordic countries. SOG aims to contribute to member brands on an international level through cooperation and joint projects. Founding members of SOG are companies such as Haglöfs, Icebug, and Peak Performance.
"We are truly honored and excited to be a part of this highly reputable group of premium brands and players in the industry. We look forward to connecting with the other members and together building a sustainable future."
- Kristoffer Ekman, CEO of NordShield®
Nordic BioTech Group, branded as NordShield®, is the world-leading innovative biotechnology company in developing new bio-based antimicrobial solutions. Founded in 2016 and headquartered in Espoo, Finland, NordShield® is disrupting the field of antimicrobial technology through a durable, wood-based alternative for antimicrobial surface protection utilized across applications and industries. NordShield®, as a commercial technology, was born after more than ten years of researching, developing, testing, verifying, certifying, and patenting. The result is a revolutionary technology with a unique combination of naturality, power and efficacy. This scalable technology enables the strongest protection with the highest innovativeness - a creation as unique and powerful as nature and one that leaves nothing but goodness behind.
For more information, visit www.nordshield.com
Contact to NordShield®:
Emmi Kavander, Chief Communications Officer / NordShield®
This document may contain statements related to Nordic Biotech Group Ltd's future business and financial performance and future events or developments that may constitute forward-looking statements. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of any such statements. Nordic Biotech Group neither intends nor assumes any obligation to update or revise these statements in light of developments that differ from those anticipated. Nordic BioTech Group Oy and its affiliates are not liable for any decision made or action taken in conjunction with the information and/or statement in this document or for any related damage.
This document contains statements that are only applicable within the European Union, and this document is intended only for distribution within the European Union. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of any such statements and is not liable for any such statements.